Participation in the European Biotech Clusters meeting, organised by the European Commission in Brussels, supports BHC’s international positioning strategy and strengthens its connections with European networks shaping the future of biotechnology.
The future of European biotechnology will also depend on stronger cooperation between regional ecosystems. Against this backdrop, Basque Health Cluster took part in European Biotech Clusters: Connect. Collaborate. Scale. in Brussels, an event organised by the European Commission’s DG SANTE, bringing together representatives from European biotech clusters and regional ecosystems to explore collaboration opportunities and discuss the challenges surrounding the development of the European Biotech Act.
Basque Health Cluster’s participation is part of its broader international positioning strategy: strengthening the presence of the Basque health and biosciences sector within European networks, building strategic partnerships and connecting associated companies with new opportunities for collaboration and innovation.
Connecting the Basque biotech sector with European networks
During the meeting, Idoia Muñoz, General Manager of Basque Health Cluster, facilitated a session dedicated to collaboration between clusters, alongside representatives from other European ecosystems, including Biocat and LithuaniaBIO.
The discussion focused on how to turn interregional cooperation into tangible opportunities for companies. Key topics included shared access to specialised infrastructures and capabilities, the development of strategic partnerships, and collaboration to accelerate innovation and industrial scale-up.
The meeting also provided an opportunity to strengthen relationships with other clusters and partners within the CEBR (Council of European BioRegions) network, a platform connecting European biotech ecosystems and supporting knowledge exchange and new opportunities for cooperation.
From European connections to industrial opportunities
Cross-regional cooperation is particularly relevant as Europe seeks to strengthen its competitiveness, biotechnology manufacturing capacity and strategic autonomy.
For Basque Health Cluster, engaging in these European platforms means helping connect the capabilities of the Basque health and biotechnology sector with European priorities and opportunities. This work is particularly relevant in areas such as advanced therapy biomanufacturing, where collaboration, access to infrastructure and the development of industrial capabilities are essential.
The meeting also concluded with concrete next steps to maintain the dialogue and move towards new collaborative initiatives.
Through this participation, Basque Health Cluster continues to strengthen its presence in European networks and its role as a connector between Basque companies and international cooperation opportunities across the health and biosciences sector.
